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ttp://dx.doi.org/10.1016/j.ajpath.2012.10.008Apoptosis signaleregulating kinase 1 (ASK1) is a mitogen-activated protein kinase kinase kinase that
plays a crucial role in stress-induced apoptosis. Recently, we have reported that suppressed macrophage
apoptosis in ASK1 and apolipoprotein E double-knockout mice accelerates atheromatous plaques in the
hyperlipidemia-induced atherosclerotic model. However, the pathogenic role of smooth muscle cell (SMC)
apoptosis in atherosclerosis still remains unclear. We investigated neointimal remodeling in ligated
carotid arteries of ASK1-deﬁcient mice (ASK1/) for 3 weeks. ASK1/ mice had signiﬁcantly more
suppressed intimal formation, inversely manifesting as potential anti-atherogenic aspects of ASK1
deﬁciency, characterized by fewer SMCs and less collagen synthesis; and fewer apoptotic SMCs, inﬁltrating
T lymphocytes, and microvessels, associated with decreased apoptosis of luminal endothelial cells,
compared with those of wild-type mice. Injured arteries of ASK1/mice also showed signiﬁcantly down-
regulated expression of pro-apoptotic markers, adhesion molecules, and pro-inﬂammatory signaling
factors. Moreover, tumor necrosis factor-aeinduced apoptosis was markedly suppressed in cultured
aortic SMCs from ASK1/mice. These ﬁndings suggest that ASK1 accelerates mechanical injuryeinduced
vascular remodeling with activated SMC migration via increased neovascularization and/or enhanced SMC
and endothelial cell apoptosis. ASK1 expression, especially in the SMCs, might be crucial, and reciprocally
responsible for various pro-atherogenic functions, and SMC apoptosis seems to be detrimental in this
model. (Am J Pathol 2013, 182: 597e609; http://dx.doi.org/10.1016/j.ajpath.2012.10.008)Supported in part by Grants-in-Aid for Scientiﬁc Research (19590413,
20590416, and 24790394) from the Ministry of Education, Culture, Sports,
Science and Technology, Tokyo, Japan (S.Y., A.T., and Y.S.).
T.T. and S.Y. contributed equally to this work.Investigations of arterial reaction against altered blood ﬂow
or mechanical injury offer potential clues for human
atherosclerosis etiology and restenosis, a major cause of
morbidity in humans.1,2 In vivo atherosclerotic vascular
lesions and remodeling, induced by unilateral carotid artery
ligation and predominantly composed of migrating and/or
replicating vascular smooth muscle cells (SMCs), with
subsequent production of extracellular matrix, have been
used as an injury model.3 In this model, partial blood stasis,
enhanced wall tension, and reduced shear stress induce
vascular remodeling proximal to the ligature site, similar to
atherosclerosis or restenosis after angioplasty.2e5stigative Pathology.
.Apoptotic cells, includingSMCs, endothelial cells (ECs), and
macrophages, are reportedly evident in atherosclerosis.6,7
Although there are few reports correlating SMC apoptosis
with neointimal vascular remodeling in ligation-mediated
atherosclerotic models, apoptosis of medial SMCs might
accelerate injury-induced neointimal formation, probably by
triggering migration and proliferation of SMCs.8 On the other
Tasaki et alhand, apoptotic intimal SMCs are often not scavenged because
of weakened phagocytic clearance (ie, efferocytosis) by
macrophages; therefore, they couldbe the sourceof extracellular
matrix, such as collagen and calcifying vesicles, or thrombin,
resulting in the intimal thickening, calciﬁcation, or thrombo-
genicity, respectively.9,10 Apoptosis of ECs could also be
important in the ligation model, because the initial step for
injury-induced atherosclerosis includes EC damage and subse-
quent inﬂammatory cell migration.6,11 Despite this, the role of
apoptosis by vascular SMCs and/or ECs in the progression of
neointimal hyperplasia is still debatable; apoptosismight also be
a part of normal vascular wound healing.12
Apoptosis signaleregulating kinase 1 (ASK1), which is
a mitogen-activated protein kinase kinase kinase family
member, is stimulated via distinct mechanisms in response to
various cytotoxic stressors, such as oxidative stress mediated
by hydrogen peroxide, endoplasmic reticulum stress, and
immune system mediators, such as tumor necrosis factor
(TNF), IL-1, or Fas ligands.13,14 ASK1 activates the c-Jun
N-terminal kinase and p38 mitogen-activated protein kinase
signaling pathways, which subsequently induce intrinsic
apoptosis through mitochondria-dependent caspase acti-
vation.13e15 More recently, our research has shown that sup-
pressed macrophage apoptosis in ASK1 and apolipoprotein
E (apoE) double-knockout (ASK1//apoE/) mice acceler-
ates macrophage-rich atheromatous plaques, coincident with
fewer necrotic cores in the hyperlipidemia-induced athero-
sclerotic model,15 unlike in the current injury-induced neo-
intimal remodeling. Reported data indicate that ASK1
signaling attenuates macrophage-rich atherosclerosis and
enhances necrotic core formation by stimulating macrophage
apoptosis, which might cause plaque vulnerability via necrotic
core development. ASK1 plays a critical role in the regulation
of macrophage apoptosis from the anti-atherogenic aspects.15
However, little is known about the relationship between
apoptosis in ASK1-induced SMCs and/or ECs and vascular
remodeling of atheroscleroticmodels. Actually, another group
has reported ASK1 activation to play a key role in vascular
neointimal hyperplasia16; however, their balloon injurymodel
on rat carotid arteries is not suitable to examine EC apoptosis
and, inconsistently, their data have not demonstrated that
dominant-negative ASK1 mutant signiﬁcantly decreases
vascular SMC apoptosis. By contrast, we suggested that
the mechanisms responsible for atherosclerosis in vascular
injuryeinduced arteries would be fundamentally different
from those at play in the high-cholesterol dieteinduced aortas
in rabbitmodels.17 Thus, in the present study,we examined the
roles of ASK1 and apoptosis of SMCs and/or ECs in ligation
injuryeinduced neointimal hyperplasia.
Materials and Methods
Animals
The experiments were performed on young male C57BL/6
wild-type (WT) and ASK1/ mice,15 weighing 20 to 25 g.598To produce the ligation-induced vascular injury model, we
ligated the left common carotid artery with a 7-0 silk suture
at a site proximal to the carotid bifurcation in two groups of
mice at the age of 6 to 8 weeks under anesthesia: an i.p.
injection of 100 mg/kg ketamine (Daiichi Sankyo Co,
Tokyo, Japan) and 2 mg/kg medetomidine (Meiji Yakuhin
Co, Tokyo). The animals were euthanized at 1, 2, or 3
weeks after injection, by an i.p. injection of an overdose of
ketamine-medetomidine, and the carotid arteries were
excised (each was bisected at both sides of the ligation site
to obtain an approximately 3-mm segment). They were then
stained with H&E, elastica van Gieson (EVG), or Masson’s
trichrome stain, or immunohistochemical (IHC) prepara-
tions in sequential sections as well, after ﬁxation in 10%
neutral-buffered formalin for 24 hours.15,17,18 Analyses
were performed in the ligated left common carotid arteries
in all experiments, whereas the contralateral nonligated right
carotid arteries served as a control.
The carotid arteries embedded in parafﬁn for histological
examination were cut systematically in sequential sec-
tions (4 mm thick) by using a sliding microtome (Leica
SM2010R; Leica Microsystems, Wetzler, Germany). The
specimens of carotid artery were thoroughly examined by
preparing sequential 500- to 750-mm cross sections for H&E
or IHC stainings. A robust and reproducible vascular
remodeling in WT mice reliably started at a distance of
500 mm from the ligature; small amounts of thrombus were
observed at the ligation site,3 and persisted up to 1500 mm
from the ligature. Of each 20 sequential sections (one set),
one was stained with H&E staining at least (ie, 80 mm thick
intervals).15,17,18 Quantifying analyses were performed in
these 15 serial H&E sections collected from segments of
approximately 500 to 1500 mm proximal to the site of
ligation, as shown in Supplemental Figure S1. Images of the
15 sections were captured, and the thickened neointimal or
medial areas and the intima/media (I/M) ratio were evalu-
ated by a NanoZoomer Digital Pathology Virtual Slide
Viewer (Hamamatsu Photonics Corp, Hamamatsu, Japan).
The EVG staining clearly revealed both internal and
external elastic lamina (EEL). In addition, the extent of
constrictive vascular remodeling (reduction in vascular
cross-sectional area) was calculated by the reduction in the
EEL length in the ligated compared with the control artery
(Hamamatsu Photonics Corp).17,18 These indices were
quantiﬁed by averaging all measurements counted in an
individual mouse; we then selected one representative
(mean) section per mouse.15,17,18 To calculate proportions of
collagen content to neointima, we measured intimal lesion
areas and Masson’s trichromeepositive blue areas in at
least three sequential sections of each previously men-
tioned set, including the representative one, as previously
described.15,18
The Ethics Committee of Animal Care and Experimen-
tation, University of Occupational and Environmental
Health (Kitakyushu, Japan) approved the protocols. They
were performed according to the Institutional Guidelines forajp.amjpathol.org - The American Journal of Pathology
Role of ASK1 in Vascular RemodelingAnimal Experiments and the Law (number 105) and Noti-
ﬁcation (number 6) of the Japanese government. The
investigation conforms to the Guide for the Care and Use of
Laboratory Animals, published by the US NIH (publication
85-23, revised 1996).
Bone Marrow Transplantation
Bone marrow specimens (5  106 cells) obtained from the
femurs of the desired donor mice (WT or ASK1/) were
transplanted into whole bodyeirradiated (9 Gy from
a cesium g source) recipients (8-week-old male WT mice),
as previously described.15,18,19 Carotid artery ligation was
performed 5 weeks after the bone marrow transplantation
(BMT); arteries were processed 4 weeks after the operation.
Immunohistochemistry
More than 10 animals from each group were analyzed. One
representative section per mouse was prepared for IHC
staining. Images from at least three sequential sections of
each previously described 20 serial set (ie, 80 mm thick
intervals), including the representative one, were captured
and evaluated by a NanoZoomer Digital Pathology Virtual
Slide Viewer to avoid potential bias.15,17e19
To detect the number of macrophages and SMCs in
neointimal lesions, we used rat anti-mouse Mac-2 mono-
clonal antibody (1:500; Cedarlane Laboratories Ltd,
Burlington, ON, Canada) for macrophages and monoclonal
mouse anti-human smooth muscle actin (a-SMA) antibody
(1:150; Dako Cytomation Co, Tokyo) for SMCs. For the
latter, we applied the HistoMouseePlus Kit (Invitrogen
Corporation, Camarillo, CA) to block the endogenous
mouse IgG. For evaluation of T-lymphocyte inﬁltration,
especially in the neointimal lesions, a polyclonal rabbit anti-
human CD3 antibody (1:1; Dako Cytomation Co) was used;
we counted CD3þ T cells.18 To count neointimal micro-
vessels, we used rat monoclonal antibody against mouse
CD31 (1:20; Dianova, Hamburg, Germany).
To analyze apoptotic or proliferative activity of inﬁltrating
cells in neointimal lesions, Bax rabbit polyclonal antibody
(1:50; Santa Cruz Biotechnology, Inc., Santa Cruz, CA) or
Ki-67 (MIB-1; 1:2000; Epitomics, Burlingame, CA) rabbit
monoclonal antibody was applied, respectively. To evaluate
ASK1 in injured carotid arteries, we used rabbit anti-ASK1
polyclonal antibody (1:50; Santa Cruz Biotechnology, Inc.).15
BrdU and TUNEL Staining
To label proliferating cells in the intimal lesion of ligated
arteries 2 weeks after ligation, 50 mg/kg body weight 50-
bromo-20-deoxyuridine (BrdU; Sigma-Aldrich, St. Louis,
MO) was s.c. injected 2 hours before sacriﬁce; BrdU-
incorporated cells were detected by IHC using a monoclonal
mouse anti-BrdU antibody (Roche Applied Science, Lewes,
UK). To detect the number of apoptotic cells in vivoThe American Journal of Pathology - ajp.amjpathol.org(2 weeks after ligation) and in vitro, TUNEL assays were
performed using an In Situ Cell Death Detection Kit (Roche
Applied Science, Mannheim, Germany).15
The ligated arteries at 2 weeks were labeled with TUNEL
reaction mixture (Roche Applied Science) and monoclonal
mouse a-SMA antibody (1:1000; Dako Cytomation Co), and
visualized with anti-ﬂuorescein antibodies (TUNEL POD;
Roche Applied Science) or goat anti-mouse IgG antibodies
conjugated with Alexa Fluor Dyes (Invitrogen, Carlsbad,
CA), respectively.18 We also applied the HistoMouse Plus
Kit (Invitrogen) to block the endogenous mouse IgG.
En Face Double-Immunoﬂuorescence Staining
En faceeprepared arteries in ASK1/ and WT mice were
ﬁxed with cold acetone for 10 minutes and air dried for
another 10 minutes, after being opened longitudinally with
careful removal of luminal blood cells and adventitial
adipose tissue, 1 week after ligation. En face vessels were
labeled with TUNEL reaction mixture (Roche Applied
Science) and rat monoclonal antibodies against mouse
CD31 (1:20; Dianova), incubated with Hoechst 33258 (0.5
mg/mL; Dojindo, Kumamoto, Japan), and visualized with
anti-ﬂuorescein antibodies (TUNEL POD; Roche Applied
Science) or goat anti-rat IgG and IgM antibodies conjugated
with Alexa Fluor Dyes (Invitrogen), respectively. Stained
tissues were placed on a glass slide, intimal side up, cov-
erslipped by surface tension, and then viewed by confocal
laser scanning microscopy (LSM5 Pascal Exciter; Carl
Zeiss, Oberkochen, Germany) with 40 UPlanApo oil
immersion objectives. Three to six representative high-
power ﬁelds (approximately 100 cells) were counted for
numbers of TUNELþ, CD31þ, Hoechstþ, and CD31þ
cells,15,18 thereby expressing the number of apoptotic ECs
as a percentage of total cells. We performed three experi-
ments per group of animals, independently.
RT-PCR and Quantitative Real-Time RT-PCR
Total RNAs were extracted with TRIzol reagents (Invi-
trogen) from left carotid arteries of mice sacriﬁced at 3
weeks after ligation injury, at an approximate distance of
500 to 1500 mm from the ligature, after careful removal of
luminal blood cells and adventitial adipose tissue, using the
contralateral nonligated right carotid arteries as controls.
All procedures were performed as previously de-
scribed.15,17e19 RNase-free conditions were used to prevent
mRNA degradation. First-strand cDNA was synthesized
with Superscript II RT (Invitrogen) using random primers,
according to the manufacturer’s instructions. Quantitative
real-time RT-PCR was performed using the TaqMan ﬂuo-
rogenic probe method with an ABI PRISM 7000 PCR
machine (Perkin-Elmer Applied Biosystems, Foster, CA).
Sequences of speciﬁc primers for RT-PCR are summarized
in Table 1. Cycling conditions were as follows: 50C for
2 minutes, 95C for 10 minutes, followed by 45 cycles of599
Table 1 Primers and Probes Used for Real-Time PCR
Oligo Sequence
ASK1
Forward 50-ACGACCACCTCAGGGTCATTC-30
Reverse 50-TGGTCAGTTTCACAAAGTGTTTATATATCAG-30
Probe 50-AGACTGAAGACACCAGCGTGGTACCTCAAGT-30
Bak
Forward 50-CTGGAACCCAACAGCATCTTG-30
Reverse 50-TGGTGAAGAGTTCGTAGGCATTC-30
Probe 50-CGGAGATGATATTAACCGGCGCTACGAC-30
Bax
Forward 50-ATGGGCTGGACACTGGACTTC-30
Reverse 50-GAGGACTCCAGCCACAAAGATG-30
Probe 50-TGGCTGGGAAGGCCTCCTCTCCTACT-30
CD54
Forward 50-CAAACAGGAGATGAATGGTACATACG-30
Reverse 50-ACCAGAATGATTATAGTCCAGTTATTTTGAG-30
Probe 50-CCATGGGAATGTCACCAGGAATGTGTACC-30
CD106
Forward 50-CTCATTCCCTGAAGATCCAGTAATTAA-30
Reverse 50-TCAAAGGGATACACATTAGGGACTGT-30
Probe 50-TGAGTGGGCCACTTGTGCATGGG-30
iNOS
Forward 50-GCAGTGGAGAGATTTTGCATGAC-30
Reverse 50-ATGGACCCCAAGCAAGACTTG-30
Probe 50-CACCACAAGGCCACATCGGATTTCAC-30
IL-1b
Forward 50-TGCACTACAGGCTCCGAGATG-30
Reverse 50-GTACAAAGCTCATGGAGAATATCACTTG-30
Probe 50-TGTCGGACCCATATGAGCTGAAAGCTCTC-30
IL-6
Forward 50-TTACACATGTTCTCTGGGAAATCG-30
Reverse 50-TTGGTAGCATCCATCATTTCTTTG-30
Probe 50-TGAGAAAAGAGTTGTGCAATGGCAATTCTGAT-30
NF-kB
Forward 50-CTGACCCCTGTCCTCTCACATC-30
Reverse 50-CCGGTTTACTCGGCAGATCTT-30
Probe 50-TGATAACCGGGCCCCCAACACTG-30
PDGF-BB
Forward 50-ACCTCGCCTGCAAGTGTGA-30
Reverse 50-CTCGCTGCTCCCTGGATGT-30
Probe 50-AGTGACCCCTCGGCCTGTGACTAGAAGTC-30
TNF-a
Forward 50-CCCAGACCCTCACACTCAGATC-30
Reverse 50-TGCTCCTCCACTTGGTGGTT-30
Probe 50-ATTCGAGTGACAAGCCTGTAGCCCACG-30
An 18s ribosomal RNA TaqMan Ribosomal RNA Control Reagents VIC
Probe was used (catalogue no. 430829; Applied Biosystems).
Tasaki et al95C for 15 seconds and 60C for 1 minute. The CT values
were measured corresponding to the cycle number at which
the ﬂuorescent emission, monitored in real time, reached
a threshold of 10 SDs greater than the mean baseline from
cycles 1 through 15. Serial 1:10 dilutions of plasmid DNA,
containing each target cDNA, were analyzed, and served as
standard curves from which we determined the rate of
change of CT values. Copy numbers of target cDNA were
estimated by standard curves. All reactions for samples were600performed in triplicate. Data were averaged from values
obtained in each reaction. To determine mRNA levels of
various genes, an mRNA expression index was used, which
is an mRNA expression level standardized by 18S ribo-
somal RNA. The mRNA expression index was calculated as
follows, in arbitrary units: mRNA expression index Z
(copy numbers of target gene mRNA/copy numbers of 18S
ribosomal RNA)  1 Arbitrary Unit.
Preparation of Aortic SMCs and Analysis of ASK1
Expression or Stress-Induced Apoptosis in Cultured
SMCs
Aortic SMCs from 4- to 6-week-old male mice, fed a normal
chow diet, were isolated after treatment with collagenase
type II solution (Gibco, Grand Island, NY) for 45 minutes at
37C incubation; the inside lumen was ﬂushed to remove
ECs.18 Aortas were cut lengthwise into square pieces
(approximately 1 to 2 mm each), placed onto two-well glass
slides in an incubator, and cultured in Dulbecco’s modiﬁed
Eagle’s medium with 10% fetal bovine serum for >3 days.
For ASK1 staining, SMCs were ﬁxed in 95% acetone for 30
seconds at room temperature, permeabilized in 0.1% Triton
X-100 for 2 minutes at 4C, and then stained with a rabbit
anti-ASK1 polyclonal antibody (1:50; Santa Cruz Biotech-
nology, Inc.) for 1 hour, washed with PBS, and reacted with
anti-rabbit Ig conjugated with ﬂuorescein isothiocyanate
(Invitrogen, Life Technologies Japan Ltd, Tokyo) for ﬂuo-
rescence staining. Cells were then observed and images
were captured immediately with a Nikon ECLIPSE E600
(Nikon, Tokyo, Japan) inverted ﬂuorescence microscope.
For TUNEL staining, aortic SMCs isolated from WT and
ASK1/ mice were incubated for 17 hours with medium
alone as a control or with medium containing TNF-a (100
ng/mL; Sigma), as previously described.15,18 These SMCs
were ﬁxed in 95% acetone for 30 seconds at room
temperature and permeabilized in 0.1% Triton X-100 for 2
minutes at 4C, and then stained with a TUNEL reaction
mixture (Roche Applied Science) for 30 minutes at room
temperature and incubated with Hoechst 33258 (0.5 mg/mL;
Dojindo) and propidium iodide (PI; 5 mg/mL; Sigma) for
ﬂuorescence double staining. Cells were then observed and
images were captured immediately with a Nikon ECLIPSE
E600 inverted ﬂuorescence microscope. Three to six
representative ﬁelds (approximately 100 cells) were counted
for the numbers of TUNELþ cells, PIþ cells, and total cells.
Thereby, the number of apoptotic macrophages was
expressed as a percentage of the total number of cells. We
performed more than three experiments, independently.
Western Blot Analysis
Proteins (100 mg) isolated from WT and ASK1/ mice
ligated arteries were separated by electrophoresis on 10%
SDS-PAGE gels and transferred onto polyvinylidene
diﬂuoride membranes (Bio-Rad Laboratories, Tokyo, Japan).ajp.amjpathol.org - The American Journal of Pathology
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Figure 1 Histological analysis of ligation injuryeinduced remodeling arteries in non-BMT mice. A: Representative sequential sections of WT and ASK1/
mice 3 weeks after ligation of the left common carotid arteries. The contralateral nonligated right carotid arteries serve as a control. EVG staining clearly
reveals both internal elastic lamina (IEL) and EEL. B: Quantitative analysis demonstrates that the ASK1/ mice signiﬁcantly suppressed neointimal lesions
compared with the WT mice, but not thickened medial ones. Thus, the I/M ratio of ASK1/ mice is more markedly decreased than that of WT mice. However,
EEL length is not signiﬁcantly (N.S.) different between the two groups of mice. On the other hand, control arteries from both mice show few intimal areas and
a low I/M ratio, along with a similar EEL length to the ligated arteries. Scale bar Z 100 mm. *P < 0.05, **P < 0.001, and ***P < 0.0001.
Role of ASK1 in Vascular RemodelingMembranes were incubated with mouse monoclonal anti-
bodies to phosphorylated (phospho)-p38 (1:200; Santa Cruz
Biotechnology, Inc.) or rabbit polyclonal antibody to Bax
(1:50; Santa Cruz Biotechnology, Inc.) for the arteries.
ELISA for PDGF-BB
Levels of serum platelet-derived growth factor (PDGF)-BB
in the ligation-injury model were measured using an enzyme-
linked immunosorbent assay (ELISA) kit, according to the
manufacturer’s instructions (R&D Systems, Minneapolis,
MN).18
Electron Microscopy
After 3 weeks, injured carotid arteries from ASK1/ and
WT mice were ﬁxed with 2.5% glutaraldehyde, and small
cut specimens (approximately 1  1 mm) of thickened
neointima were immersed in 2% osmium tetroxide and
dehydrated in ethanol. For transmission electron micros-
copy, the dehydrated tissue specimens were embedded in
epoxy resin. Silver-gold sections produced with a diamond
knife were transferred to copper grids and stained withThe American Journal of Pathology - ajp.amjpathol.orguranyl acetate for viewing on a transmission electron
microscope (JEM-1200EX; JEOL Ltd, Tokyo).
Statistical Analysis
Results are expressed as mean  SE. Statistical signiﬁcance
was analyzed using the Student’s t-test or U-test analysis,
where appropriate. P < 0.05 was considered to be statisti-
cally signiﬁcant.
Results
Expression of ASK1 under Basal Conditions and in
Ligated Arteries from Non-BMT Vascular Remodeling
Mice
Aortic SMCs isolated and harvested from WT mice
speciﬁcally expressed ASK1, but not those from ASK1/
mice, as detected by immunoﬂuorescence (Supplemental
Figure S2A). Real-time RT-PCR showed ligated and
control arteries from WT mice to markedly express ASK1,
compared with those from ASK1/ mice (P < 0.0001 and
P < 0.05, respectively) (Supplemental Figure S2B).601
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Figure 2 IHC and Masson’s trichrome analyses of ligation injuryeinduced remodeling arteries in non-BMT mice. A: Representative IHC sequential sections
of WT and ASK1/ mice 3 weeks after ligation of the common carotid arteries. B: IHC shows that the numbers of intimal a-SMAþ SMCs (light grey bars) and
Mac-2þ macrophages (dark grey bars) are signiﬁcantly smaller in the neointimal lesions of ASK1/ mice than those in the WT mice. By contrast, the
proportion of neointimal SMCs in ASK1/ mice is more signiﬁcantly predominant than in the WT mice, whereas the numbers of medial SMCs and macrophages
demonstrate no signiﬁcant (N.S.) differences between the two groups of mice. C: There are larger amounts of collagen deposits in the neointimal hyperplasia
of ASK1/ mice than those in the WT mice. Scale bar Z 100 mm. *P < 0.05, **P < 0.001.
Tasaki et alHistological Evaluation of Ligated Arteries from
Non-BMT Vascular Remodeling Mice
Quantitative analysis on sequential sections of common
carotid arteries showed that ASK1/ mice had signiﬁcantly
suppressed neointimal lesions compared with control WT
mice after ligation-induced vascular remodeling for 3 weeks
(10.8  3.1  103 mm2 versus 44.9  7.6  103 mm2; P <
0.001), but not thickened medial areas (34.3 2.3 103 mm2
versus 39.2  4.0  103 mm2; P Z 0.09) (Figure 1A).
Correspondingly, the I/M ratio of ASK1/ mice was mark-
edly decreased compared with WT mice (0.29  0.08 versus
1.09  0.16; P < 0.0001). However, EEL length was not
signiﬁcantly different between the two groups of mice
(1093 38mmversus 1161 39 mm forWT versusASK1/;
PZ 0.27). However, control arteries from both mice had few
intimal areas and a low I/M ratio, with EEL length similar to
the ligated arteries [intima, 66.7  38.5 mm2 versus 64.1 
46.1 mm2 for WT versus ASK1/ (PZ 0.23); media, 19.9
0.2  103 mm2 versus 22.9  1.5  103 mm2 for WT versus
ASK1/ (PZ 0.09); and EEL, 1167  14 mm versus 1201
 62 mm for WT versus ASK1/ (P Z 0.10)]. Therefore,
both types of mice showed little constrictive vascular
remodeling.602IHC and Masson’s Trichrome Analyses of Ligated
Arteries in Non-BMT Vascular Remodeling Mice
IHC demonstrated that the a-SMAþ SMCs were fewer
(34.8  1.7 per 0.01 mm2) in neointimal lesions of ASK1/
mice, compared with those in the WT mice, 3 weeks after
ligation-induced vascular remodeling (53.2  5.8 per 0.01
mm2; P < 0.05) (Figure 2, A and B). The number of
neointimal Mac-2þ macrophages (Figure 2, A and B)
showed a similar (borderline signiﬁcant) difference to that
of the neointimal SMCs between the two groups of mice
(5.4  1.8 versus 2.7  1.4 per 0.01 mm2 for WT versus
ASK1/; P Z 0.068). However, the proportion of cell
types in ASK1/ mice (Mac-2þ cells: a-SMAþ cells Z
6.9: 93.1%  3.5%) did not signiﬁcantly differ from that in
WT mice (ie, 9.39: 90.6%  2.8%; PZ 0.30). By contrast,
the medial SMCs and macrophages demonstrated no
signiﬁcant differences between the two groups of mice
[SMCs, 31.2  2.7 versus 31.2  2.6 per 0.01 mm2 for WT
versus ASK1/ mice (P Z 0.50); macrophages, 0.95 
0.23 versus 0.60  0.24 per 0.01 mm2 for WT versus
ASK1/ mice (P Z 0.15)].
As shown in Figure 2C, Masson’s trichrome staining
revealed that smaller amounts of collagen deposits wereajp.amjpathol.org - The American Journal of Pathology
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Figure 3 Analyses of IHC staining and gene expression of inﬂammatory signaling factors in ligation injuryeinduced remodeling arteries of non-BMT
mice. A: IHC reveals that the number of CD31þ neointimal microvessels is signiﬁcantly lower in the ligated arteries of ASK1/ mice than in that of the
WT mice. B: Similarly, the number of CD3þ inﬁltrating T lymphocytes in the neointimal lesions of ASK1/ mice is signiﬁcantly lower than that in the WT
mice. C: Real-time RT-PCR shows that the expression levels of TNF-a, IL-1b, NF-kB1a, and inducible nitric oxide synthetase (iNOS) are signiﬁcantly
down-regulated in the ASK1/ mice, compared with those in the WT and control mice. Scale bar Z 100 mm. *P < 0.05, **P < 0.001, and
***P < 0.0001.
Role of ASK1 in Vascular Remodelingdetected in neointimal lesions in the ligated arteries of
ASK1/ mice compared with those of WT mice (20.3% 
8.7% versus 76.4%  8.4%; P < 0.001).
IHC staining also showed that the number of CD31þ
neointimal microvessels was signiﬁcantly lower in the
ligated arteries of ASK1/ mice than in those of WT mice
(2.42  0.54 versus 4.56  0.89 per 0.01 mm2; P < 0.05)
(Figure 3A). Taken together, the number of CD3þ neo-
intimal T cells was signiﬁcantly decreased in the ASK1/
mice than that in the WT mice (1.42  0.50 versus 3.20 
0.50; P < 0.05) (Figure 3B).
Analysis of Gene Expression of Inﬂammatory Signaling
Factors in Ligated Arteries of Non-BMT Vascular
Remodeling Mice
Real-time RT-PCR showed that the expression levels of
TNF-a, IL-1b, IL-6, NF-kB1a, and inducible nitric oxide
synthase were signiﬁcantly down-regulated in the ligated
arteries of ASK1/ mice, compared with those in WT and
control mice (P < 0.05 or P < 0.0001, respectively)
(Figure 3C).The American Journal of Pathology - ajp.amjpathol.orgAnalysis of Expression of Phospho-p38 in Ligated
Arteries of Non-BMT Vascular Remodeling Mice
Western blot analysis revealed signiﬁcantly decreased
expression of phospho-c-Jun N-terminal kinase and
phospho-p38 in injured carotid arteries in ASK1/ mice 3
weeks after ligation, compared with that in the WT mice
(Supplemental Figure S2C).
Ultrastructural Analysis of Thickened Neointima in
Ligated Arteries of Non-BMT Vascular Remodeling Mice
Electron microscopy was performed to determine ASK1-
deﬁcient SMC phenotypes in the neointima of ligated
arteries on ASK1/ mice, demonstrating that the pheno-
types of intimal SMCs were predominantly contractile ones
containing many bundles of thick and thin myoﬁlaments
(Supplemental Figure S3). By contrast, the SMC pheno-
types of thickened neointima in the ligated WT arteries as
a control mainly showed synthetic SMCs containing large
amounts of rough endoplasmic reticulum or mitochondria
(Supplemental Figure S3).603
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Figure 4 Analysis of apoptotic activity in ligation injuryeinduced remodeling arteries of non-BMT mice. A: The numbers of both TUNELþ neointimal and
medial cells are signiﬁcantly reduced in the ASK1/ mice compared with the WT mice. B: Double-immunoﬂuorescence staining conﬁrms that these neointimal
(arrows) and medial (arrowheads) apoptotic cells (TUNELþ, green) are SMCs (a-SMAþ, red). C: The number of pro-apoptotic Baxþ cells is signiﬁcantly smaller
in the neointima of ASK1/ mice than that in the WT mice. Correspondingly, real-time RT-PCR shows greater decreases in expression of Bax and Bak in the
ligated arteries of ASK1/ mice than in the WT and control mice. Scale bar Z 100 mm. *P < 0.05, **P < 0.001, and ***P < 0.0001.
Tasaki et alAnalysis of Apoptotic Activity in Ligated Arteries of
Non-BMT Vascular Remodeling Mice
Although a small, but substantial, number of apoptotic cells
was observed in both groups of mice 2 weeks after the
ligation, the number of TUNELþ neointimal cells was
signiﬁcantly lower in the ASK1/ mice (0.4  0.1 per 0.01
mm2; P < 0.05) than in the WT mice (5.5  1.9 per 0.01
mm2) (Figure 4A). However, TUNELþ medial cells were
different between the two groups (1.18  0.03 versus
0.26  0.01 per 0.01 mm2 for WT versus ASK1/ mice;
P < 0.0001) (Figure 4A). Double-immunoﬂuorescence
staining (Figure 4B) conﬁrmed that these neointimal and
medial apoptotic cells were SMCs.
The number of Baxþ cells in the neointimal areas
was signiﬁcantly reduced in the ASK1/ mice (6.2  1.9
per 0.01 mm2) compared with the WT mice (16.2  4.3
per 0.01 mm2; P < 0.05) (Figure 4C). Correspondingly,
real-time RT-PCR demonstrated that the expression
of Bax and Bak was more signiﬁcantly decreased in
the ligated arteries of ASK1/ mice than in the
WT and control mice (P < 0.0001 and P < 0.05,
respectively) (Figure 4C).604En Face Double Immunoﬂuorescence in Ligated
Arteries of Non-BMT Vascular Remodeling Mice
The percentage of TUNELþ and CD31þ ECs was also
signiﬁcantly lower in ASK1/ mice than in WT mice 1
week after the ligation (0.6%  0.2% versus 6.3%  1.1%;
P < 0.05) (Figure 5A).
Analysis of Gene Expression of Adhesion Molecules in
Ligated Arteries of Non-BMT Vascular Remodeling Mice
Real-time RT-PCR revealed that the expression levels of
CD54 and CD106 were signiﬁcantly down-regulated in the
ligated arteries of ASK1/ mice, compared with those in
WT and control mice (P < 0.0001 and P < 0.001,
respectively) (Figure 5B).
Analysis of Proliferating Activity in Ligated Arteries of
Non-BMT Vascular Remodeling Mice
In analysis of proliferation activity, BrdUþ or MIB-1þ
cells in thickened neointimal lesions 2 weeks after ligation
were relatively few and showed no signiﬁcant differenceajp.amjpathol.org - The American Journal of Pathology
Figure 5 Analyses of en face double immunoﬂuorescence and gene expression of adhesion molecules in ligation injuryeinduced remodeling arteries of
non-BMT mice. A: Arterial ECs were analyzed by ﬂuorescence double staining with TUNEL (green) and mouse CD31 (red), and confocal laser-scanning images
were captured from the same ﬁeld (en face images). The percentage of both TUNELþ and CD31þ ECs (arrows) is signiﬁcantly lower in those from ASK1/ mice,
compared with WT mice. Apoptotic cell counts from three to six representative high-power ﬁelds (approximately 100 cells) were performed, and expressed as
percentages of apoptotic cells/total cells, stained with both TUNEL and CD31 (merged)/both Hoechst (blue) and CD31, respectively. Images are representative
of three animals per group. Original magniﬁcation, 400. Scale bar Z 50 mm. B: Real-time RT-PCR shows that the expression levels of CD54 and CD106 are
signiﬁcantly down-regulated in the ligated arteries of ASK1/ mice, compared with those in the WT and control mice. **P < 0.001, ***P < 0.0001.
Role of ASK1 in Vascular Remodelingbetween the two groups of mice [BrdU, 2.0  0.9 versus
2.2  1.2 per 0.01 mm2 for WT versus ASK1/ mice (P
Z 0.38); MIB-1, 2.7  0.9 versus 1.2  0.9 per 0.01 mm2
for WT versus ASK1/ mice (P Z 0.13)] (Figure 6A).
Because the neointimal vascular cells showed low prolif-
eration rates in our model, these data suggested that
BrdU and MIB-1 cells arise by migration, most likely
from media.Analysis of PDGF-BB Expression in Ligated Arteries of
Non-BMT Vascular Remodeling Mice
The results of ELISA demonstrated that the serum PDGF-BB
levels were signiﬁcantly lower in ASK1/ mice than in
WTmice 3 weeks after the artery ligation (875.5 70.5 versus
1172.2  158.7 pg/mL; P < 0.05) (Figure 6B). Real-time
RT-PCR also showed signiﬁcantly lower expression of
PDGF-BB in the ligated arteries of ASK1/ mice than in
WT and control mice (P< 0.0001 and P< 0.05, respectively)
(Figure 6B).The American Journal of Pathology - ajp.amjpathol.orgTNF-a (Immune System)eInduced Apoptosis in
Cultured Aortic SMCs
The nuclear morphological characteristics of SMCs were
observed after double staining with PI and Hoechst 33258;
TUNELþ apoptotic cells were analyzed in the same ﬁelds
(Figure 7). Few apoptotic cells were detected in untreated
macrophages. When the cells were incubated with TNF-a,
the apoptotic SMC count was markedly increased. How-
ever, the apoptotic cell counts with TUNEL staining were
signiﬁcantly reduced in the ASK1/ mice compared with
WT mice in experimental conditions. ASK1/ mice had
signiﬁcantly fewer TUNELþ cells compared with WT mice
after they were treated with TNF-a (1.6%  0.8% versus
31.4%  7.3%; P < 0.05).
Histological and IHC Analysis of BMT Vascular
Remodeling Mice
As with the non-BMT data, BMT mice from ASK1/
donors signiﬁcantly suppressed neointimal lesion areas605
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Figure 6 Analyses of proliferating activity and
mPDGF-BB expression in ligation injuryeinduced
remodeling arteries of non-BMT mice. A: The
thickened neointimal lesions have relatively few
BrdUþ or MIB-1þ cells, and show no signiﬁcant
differences between the two groups of mice.
Because neointimal vascular cells have low
proliferation rates in our model, this suggests that
BrdU or MIB-1 cells arise by migration, most
likely from the media. B: ELISA results show that
serum PDGF-BB levels are signiﬁcantly lower in
ASK1/ mice than in WT mice. Real-time RT-PCR
also shows signiﬁcantly greater PDGF-BB expres-
sion in ligated arteries of ASK1/ mice than in
those of the WT and control mice. Scale barZ 100
mm. *P < 0.05, **P < 0.001.
Tasaki et alcompared with WT donors [intima, 44.8  9.0  103 mm2
versus 11.8  4.6  103 mm2 for WT versus ASK1/
donors (P < 0.05); media, 43.6  3.1  103 mm2 versus
26.5  2.4  103 mm2 for WT versus ASK1/ donors (PZ
0.08)] (Figure 8, A and B). Therefore, the I/M ratio of
ASK1/ donor BMT mice was greatly suppressed versus
WT donors (0.37  0.10 versus 1.14  0.34; P < 0.05)
(Figure 8B). In IHC analysis, the number of a-SMAþ SMCs
in neointimal lesions was not signiﬁcantly different between
the two mouse groups (158.6  35.5 versus 92.8  31.9 per
0.01 mm2 for WT versus ASK1/ donors; P Z 0.10),
whereas that of Mac-2þ macrophages was signiﬁcantly
fewer in neointimal lesions of ASK1/ donors, compared606with the WT donors (25.2  7.8 versus 66.2  12.1 per 0.01
mm2; P < 0.05; data not shown). In addition, these intimal
SMCs were slightly positive for ASK1 in BMT mice from
WT donors, but not from ASK1/ donors (data not shown).Discussion
The present study demonstrates a critical role of ASK1 in
mechanical injuryeinduced vascular remodeling, because
both (non-BMT) ASK1/ mice and BMT-recipient WT
mice from ASK1/ donors have signiﬁcantly suppressed
ligation injuryeinduced neointimal hyperplasia that canFigure 7 Immune systemeinduced apoptosis
in cultured aortic SMCs. Aortic SMCs are analyzed
by ﬂuorescence double staining with PI (red-
orange) and Hoechst 33258 (blue), and TUNELþ
cells (green) are shown; images are captured from
the same ﬁeld. SMCs from WT or ASK1/ mice are
incubated with medium alone (Control) or medium
containing 100 ng/mL TNF-a. Although few
apoptotic SMCs are seen in the untreated control
mice, the percentage of TUNELþ cells (arrows) is
higher in SMCs from WT mice in the treatment,
compared with ASK1/ mice. Apoptotic cell
counts from three to six representative ﬁelds
(approximately 100 cells) for each condition are
performed, and expressed as percentages of total
cells stained with TUNEL or PI. Original magniﬁ-
cation,  200. Scale bar Z 100 mm. *P < 0.05.
ajp.amjpathol.org - The American Journal of Pathology
010
20
30
40
50
60
0
20
40
60
80
100
WT WT
0
0.5
1
1.5
2
2.5
3
3.5
ASK1 -/- WT
EV
G
B
M
T+
Li
ga
tio
n
In
tim
al
ar
ea
M
ed
ia
l a
re
a
(x 10 µm ) (x 10 µm )
I/M
 ra
tio
(x 103 µm )
* *
→ →
Figure 8 Histological analysis of ligation injuryeinduced remodeling
arteries in BMT mice. A: Representative sequential sections of BMT mice
from WT and ASK1/ donors 4 weeks after ligation of the common carotid
arteries. EVG staining clearly reveals both internal elastic lamina and EEL.
B: Similar to the non-BMT data, quantitative analysis demonstrates that
BMT mice from ASK1/ donors signiﬁcantly suppresses neointimal
lesion areas compared with those from WT donors. Scale bar Z 100 mm.
*P < 0.05.
Role of ASK1 in Vascular Remodelingbasically conﬁrm the concepts, as previously reported by
Izumi et al.16 Compared with the WT mice, the ASK1/
mice revealed potentially anti-atherosclerotic proﬁles,
including manifestations of fewer SMC-predominant in-
timal lesions and fewer neointimal microvessels, associated
with repression of apoptosis in SMCs and ECs. Although
these characteristics apparently contradict our previous
results of ASK1 and apoE double-knockout mice on a
hypercholesterolemia model,15 atherosclerosis is an ex-
tremely complex disease, orchestrated by multiple factors,
including disturbed blood ﬂow, elevated inﬂammatory
cytokines, apoptotic activity, and oxidative stress.17,18,20
Indeed, the hyperlipidemia-induced mouse atherosclerotic
model demonstrates the progression of macrophage-rich
intimal lesions with necrotic lipid cores and ﬁbrous cap
formation, reminiscent of human atheromatous plaques,
manifesting as chronic inﬂammatory disease.15 In particular,
inﬂammatory cells, especially macrophages, play crucial
roles in the hypercholesterolemia-induced atherosclerosis
via macrophage apoptosis per se.15 However, the currentThe American Journal of Pathology - ajp.amjpathol.orgmodel shows the SMC-rich neointimal hyperplasia without
deﬁnite evidence of necrotic cores, likely reminiscent of
human restenosis after angioplasty or shoulder lesions of
vulnerable atheroma, manifesting as acute to subacute
inﬂammatory disease. Similarly, SMCs, in particular, have
pivotal roles in the ligation-induced atherosclerotic model
via their own apoptotic activity. Thus, the mechanisms
responsible for atherosclerosis must be fundamentally
different between these two models, from the aspects of
predominant cell types undergoing apoptosis, at the least.
The signiﬁcantly fewer TUNELþ SMCs were found in
both the smaller neointima and media in ASK1/ mice, and
were associated with decreased Bax expression, compared
with WT mice (Figure 4). Our in vitro examination
conﬁrmed this result, because immune system (TNF-a)e
mediated apoptosis was markedly attenuated in cultured
aortic SMCs obtained from ASK1/ mice (Figure 7). These
results are in agreement with the following observations of
other groups: antioxidant therapy (using tempol) prevented
neointimal formation, along with repressed apoptosis and
migration of medial SMCs in balloon-injured rat carotid
arteries by inhibiting pro-apoptotic Bax induction21; and
vascular medial SMC apoptosis induced by diphtheria toxin
increased both medial and neointimal areas, when apoptosis
was augmented after ligation injury of mouse carotid
arteries and during vascular remodeling.22 Moreover, we
show, for the ﬁrst time to our knowledge, that reduced
apoptosis by intimal SMCs can also suppress vascular
remodeling. On the other hand, these neointimal SMCs in
the ASK1/ mice showed predominantly differentiated
contractile phenotypes, containing many bundles of thin
myoﬁlaments, rather than dedifferentiated synthetic cells
(Supplemental Figure S3), accompanied by signiﬁcantly
reduced collagen production (Figure 2). However, less
synthesis of extracellular matrix in the ASK1/ mice might
partly result from efﬁcient efferocytosis.9,10 Hayashi et al23
have shown that p38 mitogen-activated protein kinase,
downstream of ASK1 signaling, plays a crucial role in SMC
dedifferentiation when stimulated by PDGF-BB; and that
the p38 mitogen-activated protein kinase pathway partially
mediates phenotypes of vascular SMCs. The previously
described data, under conditions of ASK1 deﬁciency, reveal
that p38 signals were signiﬁcantly decreased in the ligated
arteries (Supplemental Figure S2), and may be consistent
with their suggestions. Because ASK1 is reportedly located
in a critical upstream position for many signal transduction
pathways, ASK1 deﬁciency should suppress many signals
required for cell survival, apoptosis, and differentiation.15,24
Furthermore, the en face aortic double-immunoﬂuorescence
staining (Figure 5) indicated that the blockade of the ASK1/
p38 signal can also protect CD31þ ECs against apoptosis.
Apoptosis of endothelium must be important as well,
because the initial step for injury-induced vascular remod-
eling or atherosclerosis includes endothelial damage,
increased expression of adhesion molecules, and inﬂam-
matory cell migration.11,18,20 In fact, we demonstrated that607
Tasaki et alnumbers of intimal macrophages and T lymphocytes in the
neointima of ASK1/ mice were signiﬁcantly decreased,
and associated with down-regulated expression of several
adhesion and pro-inﬂammatory genes, compared with those
in WT mice (Figures 2, 3, and 5).
Among many pro-inﬂammatory cytokines or growth
factors, PDGF expression differed signiﬁcantly between the
two groups of mice (Figure 6B). PDGF-BB, produced by
platelets, macrophages, and vascular cells at sites of
inﬂammation and damage in the arterial wall, is a strong
activator of SMC migration or replication and one of the
most important factors in atherogenesis.11,18,25 Based on our
data, considering that most intimal cells were BrdU or
MIB-1 cells (Figure 6A), stimulated PDGF secretion
would signiﬁcantly accelerate SMC migration, rather than
proliferation,22,26 into the more enhanced neointima of WT
mice, and intimal SMC dedifferentiation,23 compared with
those in ASK1/ mice. Thus, the ASK1 pathway might
also have a close relationship with PDGF-induced migratory
signaling in neointimal SMCs, although detailed molecular
mechanisms are unclear. Intimal SMCs in the WT mice
could have originated from ASK1-expressed medial SMCs,
ASK1-expressed circulating SMC precursors, or adventitial
SMC progenitors,17e19 because ASK1 is ubiquitously
expressed by multiple cell types in the vasculature.15 We
previously found that bone marrowederived progenitor cell
migration into the intima plays a critical role in initiation
and progression of atherosclerosis in histamine-deﬁcient
mice, by showing recruitment of green ﬂuorescent pro-
teinþ monocytes/macrophages and/or SMCs.19 Similarly,
the current BMT study using the ASK1/ to WT mice
(Figure 8) conﬁrmed the results obtained from the
noneBMT-ASK1/ mice (Figure 1), in which the migrated
ASK1-deﬁcient SMCs alone might have a protective role
against the ligation injuryeinduced vascular remodeling.
Also, ASK1-deﬁcient immune cells, including macrophages
and T lymphocytes, may play some important roles in this
BMT model, as well as ASK1-deﬁcient SMCs, although to
a lesser degree, because BMT replaces whole immune cells
of recipient WT mice with those of donor ASK1/ mice.
Microvessels within the intima of atherosclerotic plaques
play important roles in the growth and progression of
macrophage-rich vulnerable atheroma, associated with
promotion of intraplaque hemorrhage.27 By contrast, the
effect of intimal neovascularization on vascular remodeling
is not well described, although one study reported that the
human coronary intimal microvessels deﬁnitely played
a signiﬁcant role in the growth of plaques by supplying both
inﬂammatory cells and plasma components, such as albumin
and ﬁbrinogen.28 We can support this suggestion and
demonstrate, for the ﬁrst time to our knowledge, that more
neointimal microvessels occur in the more enhanced intimal
lesions of WT mice, together with greater inﬁltration of T
lymphocytes, macrophages, and SMCs, and up-regulated
expression of various inﬂammatory signaling factors,
compared with those of ASK1/ mice (Figures 2, 3, and 5).608Our data strongly conﬁrm the hypothesis that intimal
microvessels can promote ligation injuryeinduced vascular
remodeling and might contribute to the evolution of
atherosclerosis, by providing an extended surface area of
activated ECs to hasten further recruitment of inﬂammatory
cells and SMCs.29 Furthermore, the newly formed vascular
channels might be prone to rupture; subsequent thrombosis
formation in situ can stimulate thrombin-mediated events,
such as migration or proliferation of SMCs.28 In this
context, it is possible that ASK1 can alter the functional
characteristics of ECs that inﬂuence monocyte adhesion,
transmigration and activation of inﬂammatory cells or
SMCs, and the apoptotic activity of ECs. Despite that, we
cannot completely exclude the possibility that the signiﬁ-
cantly reduced neovascularization might partly result from
decreased intimal size in ASK1/ mice.
Therefore, our data suggest that ASK1 deﬁciency plays
critical roles in ameliorating neointimal progression,
together with reduced migration of inﬂammatory cells or
SMCs into the neointima via decreased neovascularization,
as well as repressed apoptosis of ECs and/or both medial
and intimal SMCs; and decreased synthesis of collagen-rich
matrix, at least in part, via suppressed SMC dedifferentia-
tion. A diagram depicting the crucial roles of ASK1 in the
current model is summarized in Supplemental Figure S4.
Thus, we can support the hypothesis that increased SMC
apoptosis enhances the development of neointimal hyper-
plasia and exerts detrimental effects in injury-induced
vascular remodeling. All these observations suggest that
a speciﬁc ASK1 pathway blocker could offer a therapeutic
strategy against atherosclerosis progression (eg, especially
restenosis after angioplasty), by suppressing SMC migration
and neovascularization. Furthermore, our obtained results
indicate that ASK1 expression, especially in the SMCs,
might be crucial and reciprocally responsible for various
potentially pro-atherogenic effects, unlike our recent
reports,15 revealing that ASK1-expressed macrophages
particularly played a signiﬁcant anti-atherogenic role. We
might conﬁrm that the fundamental mechanisms responsible
for atherosclerosis in these injured arteries are completely
distinguished from those in the atheromatous plaques of
aortas.Supplemental Data
Supplemental material for this article can be found at
http://dx.doi.org/10.1016/j.ajpath.2012.10.008.References
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